Gannett Escapes $500M COVID-19 Story Libel Suit, For Now
Vivera Pharmaceuticals Inc. dismissed its federal defamation lawsuit Friday against Gannett, several executives and four USA Today reporters alleging it has suffered $500 million in damages because of a story that...To view the full article, register now.
Already a subscriber? Click here to view full article